Scientech Research LLC Purchases Shares of 9,564 Agilent Technologies, Inc. $A

Key Points

• Scientech Research LLC has acquired a new stake in Agilent Technologies, purchasing 9,564 shares valued at approximately $1.12 million in the 1st quarter.
• Agilent Technologies reported $1.37 earnings per share (EPS) for the last quarter, meeting analyst expectations, with a revenue increase of 10.1% year-over-year.
• Institutional investors currently hold 87.41% of Agilent's stock, reflecting significant interest from various hedge funds and investment firms.

Scientech Research LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 9,564 shares of the medical research company's stock, valued at approximately $1,119,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Sunbelt Securities Inc. raised its stake in shares of Agilent Technologies by 640.0% in the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares in the last quarter. Whipplewood Advisors LLC increased its holdings in shares of Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after acquiring an additional 186 shares during the last quarter. Wood Tarver Financial Group LLC acquired a new stake in shares of Agilent Technologies during the 4th quarter valued at approximately $34,000. Stone House Investment Management LLC bought a new position in Agilent Technologies during the first quarter worth $30,000. Finally, Opal Wealth Advisors LLC bought a new position in Agilent Technologies during the first quarter worth $31,000.

Analyst Ratings Changes

A has been the topic of a number of recent research reports. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research report on Thursday, May 29th. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $135.00 to $140.00 and gave the stock an "overweight" rating in a report on Thursday, August 28th. Leerink Partners lifted their target price on Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Friday, May 30th. UBS Group dropped their price target on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. Finally, Barclays reissued an "equal weight" rating and issued a $125.00 price target on shares of Agilent Technologies in a report on Friday, August 29th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $139.25.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Agilent Technologies Stock Performance

A traded down $2.25 during trading hours on Friday, hitting $124.48. The company's stock had a trading volume of 449,520 shares, compared to its average volume of 1,945,791. The company has a 50-day simple moving average of $119.72 and a 200 day simple moving average of $116.07. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $35.29 billion, a PE ratio of 29.23, a PEG ratio of 3.86 and a beta of 1.24. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm's quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.